Platelet-directed gene therapy overcomes inhibitory antibodies to factor viii
Journal of Thrombosis and Haemostasis, 05/30/2012Chuah MK et al.
Some patients develop neutralizing antibodies (clinically referred to as “inhibitors”) to these exogenous clotting factors that renders further therapy ineffective. Consequently, patients with inhibitory antibodies suffer frequent bleeds, just like untreated patients.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.